Nutritional products maker USANA's prelim Q3 sales miss estimates

Reuters

Oct 10, 2025

Nutritional products maker USANA's prelim Q3 sales miss estimates

Overview

USANA preliminary Q3 net sales of $214 mln missed analyst expectations
Preliminary adjusted EPS for Q3 was negative, reflecting sales and productivity challenges
Company faced high effective tax rate impacting Q3 profitability

Outlook

USANA expects full-year sales at the lower end of previous guidance
USANA anticipates future lower tax rate due to cost alignment efforts

Result Drivers

COMPENSATION PLAN TRANSITION - Co attributes softer sales and productivity to the rollout of an enhanced Brand Partner compensation plan
HIYA SALES - Hiya's lower than anticipated customer acquisition rates led to softer sales in a seasonally strong quarter
HIGH TAX RATE - Co faced a significant increase in the effective income tax rate, impacting Q3 profitability

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Prelim Q3 Sales	Miss	$214 mln	$224.10 mln (1 Analyst)
Prelim Q3 EPS		-$0.36

Analyst Coverage

Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 56.5% above its October 8 closing price of $26.51
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw72nDPHa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2574191628"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2574191628\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2574191628?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-10 04:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2574191628","market":"nz","top_or_hot":-1,"title":"Nutritional products maker USANA's prelim Q3 sales miss estimates","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Nutritional products maker USANA's prelim Q3 sales miss estimates</title></head><body><p><span>Overview</span></p><ul><li><p>USANA preliminary Q3 net sales of $214 mln missed analyst expectations</p></li><li><p>Preliminary adjusted EPS for Q3 was negative, reflecting sales and productivity challenges</p></li><li><p>Company faced high effective tax rate impacting Q3 profitability</p></li></ul><p><span>Outlook</span></p><ul><li><p>USANA expects full-year sales at the lower end of previous guidance</p></li><li><p>USANA anticipates future lower tax rate due to cost alignment efforts</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>COMPENSATION PLAN TRANSITION - Co attributes softer sales and productivity to the rollout of an enhanced Brand Partner compensation plan</p></li><li><p>HIYA SALES - Hiya's lower than anticipated customer acquisition rates led to softer sales in a seasonally strong quarter</p></li><li><p>HIGH TAX RATE - Co faced a significant increase in the effective income tax rate, impacting Q3 profitability</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Prelim Q3 Sales</p></td><td><p>Miss</p></td><td><p>$214 mln</p></td><td><p>$224.10 mln (1 Analyst)</p></td></tr><tr><td><p>Prelim Q3 EPS</p></td><td></td><td><p>-$0.36</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 56.5% above its October 8 closing price of $26.51</p></li><li><p>The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 10 three months ago</p></li></ul><p>Press Release: <span>ID:nBw72nDPHa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nutritional products maker USANA's prelim Q3 sales miss estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNutritional products maker USANA's prelim Q3 sales miss estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-10 04:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Nutritional products maker USANA's prelim Q3 sales miss estimates</title></head><body><p><span>Overview</span></p><ul><li><p>USANA preliminary Q3 net sales of $214 mln missed analyst expectations</p></li><li><p>Preliminary adjusted EPS for Q3 was negative, reflecting sales and productivity challenges</p></li><li><p>Company faced high effective tax rate impacting Q3 profitability</p></li></ul><p><span>Outlook</span></p><ul><li><p>USANA expects full-year sales at the lower end of previous guidance</p></li><li><p>USANA anticipates future lower tax rate due to cost alignment efforts</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>COMPENSATION PLAN TRANSITION - Co attributes softer sales and productivity to the rollout of an enhanced Brand Partner compensation plan</p></li><li><p>HIYA SALES - Hiya's lower than anticipated customer acquisition rates led to softer sales in a seasonally strong quarter</p></li><li><p>HIGH TAX RATE - Co faced a significant increase in the effective income tax rate, impacting Q3 profitability</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Prelim Q3 Sales</p></td><td><p>Miss</p></td><td><p>$214 mln</p></td><td><p>$224.10 mln (1 Analyst)</p></td></tr><tr><td><p>Prelim Q3 EPS</p></td><td></td><td><p>-$0.36</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 56.5% above its October 8 closing price of $26.51</p></li><li><p>The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 10 three months ago</p></li></ul><p>Press Release: <span>ID:nBw72nDPHa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4532","symbol_name":"文艺复兴科技持仓","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nL2N3VQ0YB:1","article_id":"2574191628","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2574191628","pubTimestamp":1760041296,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Nutritional products maker USANA's prelim Q3 sales miss estimatesOverviewUSANA preliminary Q3 net sales of $214 mln missed analyst expectationsPreliminary adjusted EPS for Q3 was negative, reflecting ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4183":"个人用品","USNA":"优莎娜"},"translate_title":"营养品制造商USANA第三季度prelim销售额未达预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":0.9},"content_text":"Nutritional products maker USANA's prelim Q3 sales miss estimatesOverviewUSANA preliminary Q3 net sales of $214 mln missed analyst expectationsPreliminary adjusted EPS for Q3 was negative, reflecting sales and productivity challengesCompany faced high effective tax rate impacting Q3 profitabilityOutlookUSANA expects full-year sales at the lower end of previous guidanceUSANA anticipates future lower tax rate due to cost alignment effortsResult DriversCOMPENSATION PLAN TRANSITION - Co attributes softer sales and productivity to the rollout of an enhanced Brand Partner compensation planHIYA SALES - Hiya's lower than anticipated customer acquisition rates led to softer sales in a seasonally strong quarterHIGH TAX RATE - Co faced a significant increase in the effective income tax rate, impacting Q3 profitabilityKey DetailsMetricBeat/MissActualConsensus EstimatePrelim Q3 SalesMiss$214 mln$224.10 mln (1 Analyst)Prelim Q3 EPS-$0.36Analyst CoverageWall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 56.5% above its October 8 closing price of $26.51The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 10 three months agoPress Release: ID:nBw72nDPHaFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}